Cold agglutinin disease is a type of autoimmune hemolytic anemia. This is where the immune system mistakenly attacks RBCs, causing them to break down in a process known as hemolysis.

Take-aways from a discussion on the management of cold agglutinin disease, with expert insight on navigating the healthcare system to optimize patient care.

Payers comment on main drivers of health care utilization among patients with cold agglutinin disease. ... they’re very objective, they’re very easy to get our hands on.

Cold agglutinins are found in almost everyone’s blood, but in high numbers they can lead to cold agglutinin disease. This can be the result of such things as certain infections, autoimmune ...

Q: What are the symptoms for cold agglutinin disease, and how is it diagnosed? – P.W.

The regimen used to treat chronic cold agglutinin disease in several case studies [4,5,6,7,8,9] and in 1 small trial was 375 mg/m 2 weekly for 4 doses. References Medscape Pharmacists. 2002;3(2 ...

Recordati is acquiring Sanofi’s Enjaymo, the only approved drug for the rare blood disorder cold agglutinin disease. Achieving sales milestones could bring the deal’s value to more than $1 ...

DEAR DR. ROACH: What are the symptoms for cold agglutinin disease, and how is it diagnosed? — P.W. ANSWER: Cold agglutinin disease is a specific type of anemia where antibodies attack and ...

Cold Agglutinin Disease Associated with Greater Than Twofold Increased Risk of Mortality in First Five Years After Diagnosis Contacts Bioverativ Inc. Tracy Vineis, +1 781-663-4376 [email protected] ...

FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease. News release. February 4, 2022.

ANSWER: Cold agglutinin disease is a specific type of anemia where antibodies attack and destroy a person’s own red blood cells. Unlike the usual type of autoimmune hemolytic ( “hemolytic” means ...